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ABSTRACT 
A major part of membrane function is conducted by proteins, both integral and peripheral. 
Peripheral membrane proteins temporarily adhere to biological membranes, either to the lipid 
bilayer or to integral membrane proteins with non-covalent interactions.  The aim of this study 
was to construct and analyze the interactions of the human plasma membrane peripheral 
proteins (peripherome hereinafter).  For this purpose, we collected a dataset of peripheral 
proteins of the human plasma membrane.  We also collected a dataset of experimentally 
verified interactions for these proteins.  The interaction network created from this dataset has 
been visualized using Cytoscape.  We grouped the proteins based on their subcellular location 
and clustered them using the MCL algorithm in order to detect functional modules.  
Moreover, functional and graph theory based analyses have been performed to assess 
biological features of the network.  Interaction data with drug molecules show that ~10% of 
peripheral membrane proteins are targets for approved drugs, suggesting their potential 
implications in disease.  In conclusion, we reveal novel features and properties regarding the 
protein-protein interaction network created by peripheral proteins of the human plasma 
membrane. 
 
KEYWORDS: peripheral membrane proteins; protein-protein interaction network; human 
plasma membrane; peripherome; interactome; diseases 
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1. INTRODUCTION 
Since the completion of the human genome project in 2001 [1], the analysis of large datasets 
containing biological information has risen in an unprecedented degree.  One field that has 
had a significant development in the last decade is that of proteomics [2].  The function and 
molecular properties of individual proteins have been studied extensively and information 
collected was deposited in databases like UniProt [3].  But proteins scarcely ever act 
individually [4].  Large molecular complexes, formed by interacting proteins perform 
numerous biological processes vital to the cell’s lifecycle.  Protein-protein interactions (PPIs) 
are an integral part of virtually every process that takes place in the human cell [5].  These 
interactions can be permanent or transient, between homo-oligomers or hetero-oligomers and 
obligate or non-obligate [6] and can be detected by experimental procedures [7].  Many high-
throughput experimental methods are used for the detection of interactions, such as yeast two-
hybrid (Y2H) [8], affinity purification mass spectrometry (AP-MS) [9] and protein chip 
technology [10].  Both low and high-throughput interaction data are deposited in public 
databases [11].  A compilation of these databases can be found on Pathguide - a meta-
database of more than 190 biological pathway and network databases [12].  From all these 
repositories, the interaction databases most commonly used by the scientific community are 
DIP [13], MINT [14] and IntAct [15, 16], the main co-founders of IMEx [17], the 
International Molecular Exchange Consortium.  IMEx provides an expertly curated, non-
redundant set of molecular interactions from a network of 10 collaborating major public 
interaction databases.  IMEx together with HUPO-PSI (HUman Proteome Organization - 
Proteomics Standard Initiative) [18] have defined the MIMIx [19] (Minimal Information 
about a Molecular Interaction) standard, which improves the quality of data and the curation 
of molecular interactions.  Protein-protein interaction networks (PPINs) may help us to have 
an insight of the cell’s functions.  In PPINs, proteins are represented by nodes and their 
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interactions by edges in a graphical view.  There have been studies to explore human large-
scale protein-protein interaction networks [20].  The first efforts to create a systematic map of 
protein-protein interactions was through large-scale Y2H experiments [21] and recently, 
efforts have been made to map interactions through next generation sequencing techniques 
[22].  These and other efforts are combined in the Human Interactome Database [21-23].  
Protein Interaction Networks can be of significant value in the analysis of a protein dataset as 
they may provide a complementary view of the biological pathways in which the proteins 
participate in and reveal aspects of their functions[24, 25].  However, missing and misleading 
information through false negatives and false positives that are integrated via various 
experimental approaches of protein interaction identification can cause problems during the 
analysis of the results [24]. 
Membrane proteins are of central importance to the cell as they take part in: ion, 
metabolite and macromolecule transport across membranes; signal transduction; cell 
adhesion; cell-cell communication; protein anchoring to specific locations in the cell; 
regulation of intracellular vesicular transport; control of membrane lipid composition and the 
organization and maintenance of organelle and cell shape [26].  Membrane proteins can be 
distinguished based on their association with the membrane: transmembrane proteins span a 
biological membrane one or more times, lipid-anchored proteins interact covalently with a 
fatty acid, which anchors to the membrane and peripheral membrane proteins associate with 
integral membrane proteins or/and the lipid bilayer reversibly.  Peripheral membrane proteins 
are indispensable for the cell’s proper function as they have numerous functions; from 
enzymes and electron carriers to polypeptide ligands (like hormones, toxins and inhibitors) 
and structural domains [27].  In addition, they are as essential to membrane structure as 
transmembrane proteins, as their arrangement may affect the membrane conformation, 
stability, biological activity, folding and the binding of other biomolecules [27].  Peripheral 
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proteins have been shown to have membrane binding domains, a fact consistent with their role 
in signal transduction and membrane trafficking [28].  These domains are significant for the 
recognition of lipids and thus allow these proteins to interact with the membrane.  Peripheral 
proteins have also been proposed as potential drug targets mainly due to their interactions 
with membrane lipids [29].  Moreover, specialized membrane microdomains enriched in 
sphingolipids and cholesterol, termed lipid rafts, compartmentalize cellular processes and can 
sometimes be stabilized to form larger platforms through protein-protein interactions [30].  
The presence of peripheral membrane proteins in lipid rafts can be of great importance, since 
proteins in these components take part in endocytosis, transcytosis, signal transduction and 
receptor recycling among other important cellular processes [31]. 
Having such a crucial role, membrane proteins are not studied only as distinct units 
but as complexes too.  Studies for the construction of membrane protein PPINs have been 
conducted in the past few years [32-34], however, these studies are not focused on human cell 
membranes but on membranes of other organisms, prokaryotes [32] and eukaryotes [33] as 
well.  The aim of our study was to identify and analyze the molecular interactions of 
peripheral membrane proteins in order to obtain insights about their role across the human 
plasma membrane. 
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2. METHODS 
2.1. Dataset of peripheral membrane proteins 
To collect the dataset of human peripheral membrane proteins a search was conducted in 
UniProtKB/Swiss-Prot [3].  Proteins that in their subcellular location field were 
experimentally annotated as “peripheral membrane proteins” were collected.  Proteins with 
probable, potential or by similarity confidence regarding that field were excluded from the set.  
These proteins were grouped based on their presence in various organisms and organelles and 
a dataset of peripheral membrane proteins from Homo sapiens that interact with the plasma 
membrane was constructed.  In addition, an extensive literature search was performed in order 
to identify additional proteins belonging to this category.  The final dataset created includes a 
total of 277 human peripheral membrane proteins of the plasma membrane (Table S1). 
 
2.2.  Collection of Protein-Protein Interaction data 
Using the Accession Numbers (ACs) collected from UniProtKB/Swiss-Prot for the dataset of 
277 peripheral membrane proteins, a query was submitted in IMEx [17].  This query provided 
a set of interactions for a subset of 249 proteins and only protein interactions between human 
proteins were used, excluding interaction data with viral proteins. This resulted in a final 
dataset of 238 peripheral membrane proteins with molecular interactions.  The file containing 
the interactions was formatted in MITAB 2.5 format [35], which describes only binary 
interactions for one pair of interactors in each row (Table S2).  In addition to the network 
generated using IMEx, a network using interactions deposited in IntAct [15, 16] was created 
to exclude possible misleading results by low quality interactions.  For this reason, all 
interaction data originated from spoke-expanded co-complexes and with an IntAct MI-score 
lower than 0.6 were filtered out (Table S3). 
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2.3. Visualization and analysis of the network  
For the visualization of the network, both Cytoscape 2.8.3 [36] and Cytoscape 3.0.0 were 
used, since Cytoscape 2.8 offers a plethora of plugins not yet available for Cytoscape 3.0, 
whereas the latter provides for several novel and improved options.  The dataset of 
interactions described above was visualized based on the different properties of its proteins, 
such as their subcellular location.   
To perform a graph theory based analysis, the plugin NetworkAnalyzer [37] for Cytoscape 
was utilized.  Using NetworkAnalyzer, a comprehensive set of topological parameters was 
computed and analyzed. These parameters include the number of nodes, edges, and connected 
components; the network diameter (the largest distance between two nodes), radius (the 
minimum among the non-zero eccentricities of the nodes in the network), density (the density 
of the network’s population with edges), centralization (the measurement that shows whether 
the nodes of the network have on average the same connectivity or a star-like topology), 
heterogeneity (shows the tendency of a network to contain hubs), and clustering coefficient (a 
measurement of a graph’s tendency to be divided into clusters); the characteristic path length 
(the average number of connections between nodes, which must be crossed in the shortest 
path between any two nodes); and the distributions of node degrees, neighborhood 
connectivities, average clustering coefficients, and shortest path lengths.  To investigate the 
contribution of certain nodes to the network stability attacks were conducted by removing the 
nodes in descending order of degree and calculating the characteristic path length (CPL) of 
the network in each case.  CPL is commonly used in order to measure the network stability 
[38-40]. 
From the interaction data all the 2374 interactors were isolated, and for each protein in 
that set the subcellular location was examined.  All proteins were categorized based on their 
subcellular location in the following categories: Cytoplasm (396), Endomembrane system 
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(182), Lipid-anchor (25), Membrane (239), Mitochondrion (143), Nucleus (851), Peripheral 
(242), and Secreted (228) including (39) extracellular Peripheral proteins.  For proteins that 
could not be categorized 7 prediction algorithms (pTarget [41], TargetP [42], WOLF-PSORT 
[43], BaCelLo [44], PredSL [45], LocTree2 [46] and GOASVM [47] ) were used, in order to 
include them in one of the categories described above, if three or more algorithms agreed in 
their prediction.  If the subcellular location still could not be predicted that field was 
characterized as unknown (Table S4).  Moreover, using data described in [48], the presence of 
the network’s proteins in lipid rafts was examined (Table S5). 
Interactions with drugs for the peripheral membrane proteins of the network were also 
collected, conducting a search in DrugBank [49, 50].  The 121 drugs collected were 
categorized in 31 categories according to the field “indications” as described in the DrugCard, 
thus creating the layer of diseases.  The drugs were also classified in 28 groups based on the 
drug category in which they belong (e.g. anticoagulants).  The network created by these data 
was visualized using Arena3D [51, 52].  Arena 3D uses staggered layers in 3D space, 
allowing the user to group related data into separate layers; in this case, the proteins, the drugs 
and the indications/diseases.  All data from the drug association analysis are available in 
Tables S6 and S7.  
 
 
2.4. Clustering and Functional Analysis of the network 
ClusterMaker is a Cytoscape plugin that implements several clustering algorithms and 
provides network views of the results [53].  From the algorithms provided, the MCL (Markov 
Clustering) algorithm was chosen, in search of clusters that represent macromolecular 
complexes in the cell [54].  The MCL algorithm appears to be superior in comparison with 
other clustering methods in detecting clusters in sets of high-throughput interaction data [55, 
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56].  The clusters detected were compared with known complexes found in the Mammalian 
Protein-Protein Interaction Database (MIPS) [57] using the Comprehensive Resource of 
Mammalian protein complexes (CORUM) [58] in order to detect possible novel components 
of the known complexes. The data for protein complexes deposited in CORUM are manually 
annotated and data from high-throughput experiments are excluded. For the functional 
analysis of the network, two (2) online tools that perform GO term enrichment analysis 
(Gorilla [59]) and GO slim classification (WebGestalt [60, 61]) were used.  The analysis was 
performed for two (2) different datasets: that of the 238 peripheral membrane proteins and, 
also, the complete set of the network’s proteins, 2374 proteins totally, to study the molecular 
functions and biological processes in which they participate, as well as the cellular 
components in which they are located.  A set of all the network’s proteins from which the 
peripheral membrane proteins had been removed was used as a background set for the 
functional enrichment analysis of the 238 peripheral membrane proteins in order to examine 
their function in the human plasma membrane peripherome.  All data derived from the 
clustering and the functional analyses are available in Tables S8, S9 and S10. 
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3.  RESULTS  AND DISCUSSION 
 
3.1 Collection of the Protein-Protein Interaction data 
As mentioned above from all the peripheral membrane proteins that were collected, 249 were 
shown to have interactions in IMEx.  These proteins had 4336 interactions isolated from all 
the databases participating in the consortium (DIP, I2D-IMEx, InnateDB-IMEx, IntAct, 
MatrixDB, MINT, MolCon, UniProt) except MPIDB, which contains data for microbial 
proteins and MBInfo, which is a specialized database focusing on mechanobiological 
interactions.  After the removal of non-human proteins and their interactions, 2374 proteins, 
including 238 peripheral membrane proteins, were shown to have 3445 interactions.  We 
resubmitted a query in IMEx for all 2374 proteins and resulted in a final dataset of 16961 
interactions between the 2374 proteins of our network.  The 2374 proteins were the nodes and 
their interactions were the edges that created the network, which was later used in the 
analysis.  The additional network created using data gathered from IntAct consisted of high 
quality interactions only having 691 nodes and 855 interactions between them. 
 
3.2. Analysis of the network 
3.2.1. Analysis of network structure based on graph theory 
For a deeper understanding of the network’s functions, its topological parameters were 
calculated.  Topological parameters can be calculated both for directed and undirected 
networks.  In our case, the parameters were calculated for an undirected network (see 
Methods 2.3).  The simple parameters that give certain information for the network are: the 
clustering coefficient (0.121), the characteristic path length (3.260), the average number of 
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neighbors (13.177), the network density (0.006) and the network heterogeneity (1.765).  
Moreover, the complex parameters were calculated in order to obtain a better view of the 
network.  Such parameters are the node degree distribution and the average clustering 
coefficient (Fig.1).  By examining the network’s properties one-by-one, interesting 
information can be obtained.  Starting with the network density, it was observed that it has a 
low value (<0.1) [62].  This is a characteristic often present in many biological networks and 
it has been argued that biological networks are generally sparsely connected, as this confers 
an evolutionary advantage for preserving robustness [63].  Another important measure is the 
clustering coefficient.  In random networks, the clustering coefficient is approximately 1/N, 
where N is the number of the nodes of the network [64].  Biological networks have 
significantly higher clustering coefficients compared to random ones -as is the case here-, 
which shows that cellular processes are executed by subsets of molecules forming functional 
modules [63], as seen during the MCL clustering process.  
The understanding of the topology of a network can give insights relevant to its 
biological significance.  The basic parameter that reveals the topology of a network is the 
node degree distribution (Fig. 2A).  In our case the distribution is of the form: 
( ) 383.18.1015 −= kkP         (3.1) 
In scale-free networks the probability P(k) that a vertex in the network interacts with k 
other vertices decays as a power law, following P(k) ~k-γ - as is the case here - where γ is the 
degree exponent [65].  The value of γ determines important properties of the network.  In 
cases where the value of γ<2, the role of the hubs in the network becomes more important, 
than in most cases where 2<γ<3 [66].  Biological networks are robust against random node 
failures, but disruption of hubs (proteins with a large number of links)  often leads to system 
failure [67].  Scale free networks have average path lengths significantly smaller than that of 
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random networks.  To compute the average path length for a random graph we used the 
formula introduced by Fronczak et al. [68]  
2
1
ln
ln
+
−
=
k
Nlrandom
γ          (3.2) 
where γ=0.5772 is Euler’s constant.  For this case, the average path length is 7.55, which is 
larger than 3.26 – the characteristic path length of the network.  From these data we can 
observe that the network has a scale-free topology, where the hubs hold the network together 
[69].  Proteins with high node degrees (>30) are considered hubs in the network.  These 
proteins have various functions: from receptors for GABA (UniProtKB AC:Q9H0R8) and 
estrogens (UniProtKB AC:P03372) to structural proteins like fibronectins (UniProtKB 
AC:P02751) and microtubule associated proteins (UniProtKB AC:Q9H492), all important for 
the sustention of the cell’s homeostasis and precise function.  For instance, knockout of the 
von Hippel-Lindau tumor suppressor, a peripheral membrane protein (UniProtKB 
AC:P40337), which is also a hub in our network, causes prenatal lethality due to 
abnormalities in the morphology of various organs during the development and organogenesis 
of the embryo in mice [70-72]. 
As stated above, for random networks the clustering coefficient is C ~ 1/N, and in this 
case C ~ 4.21·10-4 which is very small compared to the clustering coefficient of the network 
(0.121).  This combined with the fact that the average path length of our network is small 
compared to that of a random network, indicates a small-world network [73].  Small-world 
networks can efficiently transmit information between distant nodes (small path length), while 
simultaneously process local information efficiently (high clustering coefficient) [74].  For 
example, in our network, a peripheral protein with a high clustering coefficient and a small 
average path length is the subunit sigma of AP-2 complex (AP2S1) (Fig.S1).  This protein is 
part of the adaptor protein complex 2, which functions as a protein transporter in different 
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membrane traffic pathways via transport vesicles and is involved in clathrin-mediated 
endocytosis.  This protein interacts in our network with three (3) other proteins -Epidermal 
growth factor receptor substrate 15 (EPS15), Growth factor receptor-bound protein 2 (GRB2) 
and Vascular cell adhesion protein 1 (VCAM1)-, which take part in signal transduction and 
cell-cell recognition.  These proteins in turn interact with 510 other proteins in the network.  
This signifies AP2S1 as a “bottleneck” and a very important protein for the network’s normal 
function and subsequently the cell’s vitality.  Its removal would destroy many links between 
the 510 proteins that are now connected.  Interestingly, knockouts of GRB2 and VCAM1 lead 
to pre-natal lethality in mice [75, 76].  Using data collected from the Mouse Genome 
Database (MGD) [77] we were able to characterize the hubs and bottlenecks of the network as 
proteins encoded by essential (knockout of these genes in mice produce lethal phenotypes) 
and non-essential genes for the organism’s development (Table S11).  We observe that 52% 
of hubs in the network of the plasma membrane peripherome, and 25% of bottlenecks are 
essential proteins as knockouts of their protein-coding genes results in abnormal survival 
(lethality) in mice.  More details about the top 10 hubs and bottlenecks of this network are 
presented in Table S12. 
To examine whether a protein shares interaction partners with other nodes in the 
network the topological coefficient has to be measured [78].  The topological coefficient 
decreases with the number of links (Fig. 2C), which is an indicator that hubs in the network 
are as connected as the rest of the network’s proteins, thus suggesting that hubs in the network 
are not clustered together.  It also indicates, in compliance with the clustering coefficient, that 
the network has a modular organization [25]. 
The gradual removal of proteins present in lipid-rafts and peripheral membrane 
proteins of the human plasma membrane in descending order of node degree (‘attacks’ [40]) 
caused a more rapid increase in the characteristic path length (CPL) of the network compared 
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to the removal of the same proportion of randomly selected nodes from the whole network 
(commonly described as ‘failure’ [40]) (Fig.3). The increase in the network’s CPL shows the 
importance of the removed proteins as mediators of intracellular communications, since the 
paths connecting the remaining nodes in the network are longer (Table S13).  This effect on 
the CPL for peripheral membrane proteins and lipid raft related proteins in the human plasma 
membrane peripherome indicates their importance for the stability and proper function of this 
cellular sub-network. 
The network structure and topology is similar for the network created using only high-
quality data present in IntAct.  P(k) decays as a power law, following P(k) ~k-γ 
( ( ) 036.27.474 −= kkP ), the clustering coefficient of the network is larger than that of a random 
network and the average path length is smaller.  The IntAct network has a scale-free topology, 
small-world properties as well and the complex parameters of this network have similar 
distributions to those mentioned for the network created using data from IMEx, thus 
suggesting that the differences between the two networks are not such to suggest that the 
presence of data from high-throughput experiments have a severe effect on the networks 
topology and characteristics. 
 
3.2.2. Analysis based on the proteins’ subcellular location 
All the network’s proteins were categorized based on their subcellular location (Fig. 4).  The 
main observation was that peripheral proteins interact with proteins that have multiple 
subcellular locations and are not mainly localized in the plasma membrane as perhaps 
expected.  Peripheral membrane proteins of the plasma membrane constitute a central node 
connecting the plasma membrane with the entire cell, as they can detach themselves from the 
membrane plane and interact with proteins with multiple subcellular locations inside the cell.   
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Through this transient membrane association, they are involved in protein transport 
and are essential for the regulation of vesicle transport [79].  This is indicative of the central 
importance of the peripheral membrane proteins, as they constitute a sub-proteome, pivotal 
for the cell’s metabolism and function.  Another observation made was the preference of 
extracellular peripheral membrane proteins to interact with transmembrane proteins, and 
especially single-pass transmembrane proteins of the plasma membrane.  The majority of 
single-pass transmembrane proteins belongs to type I (proteins spanning the membrane once, 
with their N-terminal on the extracellular side of the membrane and their signal peptide 
removed) and are associated with the immune system.  This is consistent with the fact that the 
secreted peripheral proteins are mainly associated with inflammatory processes and so it is 
logical for these proteins to interact with other proteins of the immune system like 
interleukins, antigens and cytokines.  Approximately 50% of transmembrane proteins of the 
human plasma membrane peripherome act as receptors and almost a quarter of them present 
catalytic activity (Table S15).  Interestingly, 182 (ca.8%) of proteins in the human plasma 
membrane peripherome are located in lipid rafts and 45% of them have catalytic activity 
while 29% act as receptors.  The distribution of the proteins amongst the various subcellular 
locations is not affected by the removal of “low quality” interactions - as shown through the 
analysis of their distribution in the network composed from data collected from IntAct (Table 
S14). 
 
3.2.3. Analysis of peripheral membrane proteins’ interactions with drugs 
From the data collected from DrugBank [49, 50], a correlation between drugs and 
diseases was made based on the field “Indications”.  Peripheral membrane proteins and drugs 
interacting with them are associated mainly with cardiovascular and blood associated 
diseases, and cancer.  There are also a few proteins associated with asthma, arthritis and 
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skeletal disease.  It was observed that ca. 10% of the peripheral membrane proteins in the 
plasma membrane are targets for ca. 10% of approved drugs.  But if the peripheral membrane 
proteins are examined based on their subcellular location the case is different, since 40% of 
extracellular peripheral membrane proteins have interactions with at least one drug. There is 
also a correlation of “drug category” (as described in the Drugbank card) and the proteins’ 
subcellular locations:  the majority of the drugs belong to a category in which all of them 
interact with proteins that are either in the cytoplasmic (e.g. drugs that belong to the category 
of contraceptives) or the extracellular (e.g. drugs that belong to the category of 
anticoagulants) side of the plasma membrane.  Interactors (Fig. S2) are proteins in the 
network, which interact with the peripheral proteins of the plasma membrane that are 
associated with drugs (as described above).  These interactors are categorized - based on their 
association with the membrane plane - to six distinct categories:  multi-pass transmembrane 
proteins, single-pass transmembrane proteins, peripheral membrane proteins, secreted 
proteins, intracellular proteins and other.  It was observed that extracellular peripheral 
membrane proteins interact mostly with single-pass transmembrane proteins and secreted 
proteins.  This was also observed for all the extracellular peripheral proteins mentioned in the 
previous section. A certain example for Alzheimer’s disease is given in Fig. S2, where the 
drugs associated with this disease, the proteins connected with these drugs and their 
interactors are selected. 
 
3.2.4. Functional Analysis of the Network 
From the GO term slim classification it is apparent that the 2374 network’s proteins take part 
in metabolic processes (especially protein modification), biological regulation (especially 
intracellular protein kinase cascade), apoptotic processes and intracellular transport.  The 
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cellular components in which most proteins are located in are the cellular membranes and the 
nucleus, a fact additionally present in their categorization based on subcellular location (Fig. 
4).  As for the protein molecular functions all the network’s proteins take mainly part in 
protein (especially ubiquitin protein ligase and nuclear hormone binding) and ion (ATP) 
binding and present catalytic activity (protein kinase), but peripheral membrane proteins take 
part in lipid binding to a much larger degree than the rest of the proteins in the network.  This 
is relevant with the fact that the majority of peripheral proteins that interact directly with the 
membrane have lipid binding domains [80]. 
More detailed results were gathered through the GO term enrichment analysis 
conducted using GOrilla [59].  In the results of the enrichment analysis every biological 
process, molecular function and cellular component is associated with certain proteins in the 
network and a P-value is given to each association according to its significance (lower values 
correspond to larger significance).  Processes with fairly low P-values (10-10 – 10-6) for all the 
network’s proteins present in the results of the analysis were ATP synthesis coupled proton 
transport, cholesterol efflux and TAP-independent antigen processing and presentation of 
exogenous peptide antigen via MHC class I.  However, only a small number of proteins is 
associated with these processes (up to 1%), thus implying that they could belong to a certain 
cluster of the network and that they are not representative of the process that the whole 
network is conducting.  Applying the same logic for molecular function and cellular 
components we were able to isolate such examples like G-protein coupled amine receptor 
activity, MHC class I receptor activity and translation factor activity for molecular function 
and  triglyceride-rich lipoprotein particle, clathrin adaptor complex and AP-type membrane 
coat adaptor complex for cellular components.  For the peripheral proteins in particular there 
was an evident association with the plasma membrane and the cytoskeleton.  As noticed 
during the slim classification process as well, peripheral proteins participate in lipid binding 
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and especially phospholipid binding and regarding biological processes, those showing an 
overrepresentation are the regulation of signaling, cell communication and phosphate 
metabolic processes. 
 
3.2.5. Network Clustering 
For the detection of macromolecular complexes in the network, the MCL clustering algorithm 
was used (see Methods).  The inflation parameter was set to 1.8. This value has been shown to 
give the best results regarding the identification of functional modules in PPINs [55].  The 
algorithm detected 160 complexes in total.  For these complexes we performed functional 
analysis using the WebGestalt toolkit, in order to detect biological similarities between the 
proteins in each complex.  We selected the human genome as a reference gene set in order to 
perform enrichment analysis to obtain information from all the databases in WebGestalt (see 
section 2.4 above).  We evaluated the data obtained from these analyses for all the protein 
clusters at hand, and assigned a specific biological activity or disease to those complexes that 
a significant correlation with specific terms could be made.  This allowed us to retrieve 45 
macromolecular complexes with a certain function. Some of these complexes are depicted in 
Fig. 5.  The complexes in the network take part in a long range of processes inside the cell, 
from cell division to the regulation of matrix adhesion and antigen processing and 
presentation, thus revealing the central role of peripheral proteins in multiple cell functions.  
In Fig. 5B some of the protein complexes that have a relation with diseases are shown.  The 
diseases with which the clusters’ proteins associate are mainly infectious diseases (e.g. 
AIDS), cardiovascular and blood diseases and disorders (e.g. hypertrophic cardiomyopathy 
and polycythemia vera) and cancers (e.g. acute myeloid leukemia).  The peripheral membrane 
proteins in these complexes are of central importance and further drug research should focus 
on them as they appear to be central nodes connecting proteins related to the same disease. 
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All 45 complexes indentified were compared with known complexes in MIPS [57].  
25% of these complexes were partially correlated with complexes deposited in MIPS.  Two 
characteristic examples are shown in Fig.S3.  The first is the endosomal sorting required for 
transport complex ESCRT-III, which is required for intracellular transport [81].  Seven 
proteins of this cluster are known components of this complex.  There is a potential novel 
member of the ESCRT-III complex present in this cluster.  It is a Multivesicular Body Protein 
(MBP) involved in BD formation, a function conducted by ESCRT-III complex consisting 
this protein a probable core component of ESCRT-III [82].  The other proteins in this 
complex are associated with other ESCRT complexes [83] or cell trafficking in general [84] 
and could possibly be components of this complex as well since their function has not been 
studied extensively.  The second is the mTORC2 complex, a protein complex regulating the 
cytoskeleton.  Two of the proteins not currently in the complexes in MIPS are described as 
potential members of the mTORC2 complex [85, 86] (Fig.S3).  In addition, all complexes 
were examined for the existence of peripheral proteins and proteins located in lipid rafts 
(Table S5). 
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4. CONCLUSIONS 
Almost 50% of human proteins are intrinsic or peripheral to cellular membranes [80] 
and are one of the most important components of the human cell.  In this work we studied the 
interactions of peripheral proteins of the human plasma membrane and analyzed various 
properties of the interaction network in order to obtain a better understanding of the 
characteristics of the human plasma membrane peripherome.  We observed that the network 
possesses the characteristics of biological networks, thus having a scale-free topology and 
small world properties.  Further analysis, indicated proteins which are essential for 
maintaining the connectivity and stability of the network.  Removal of these proteins leads to 
deleterious effects on cells and lethal phenotypes in mammals.  Peripheral membrane proteins 
and proteins of the network located in lipid rafts are important for the stability of the human 
plasma membrane peripherome and have a greater contribution to the stability of the whole 
network than other proteins since their removal leads to network destruction.  Peripheral 
membrane proteins are targets for ca.10% of approved drugs and are associated with multiple 
diseases.  There are also other proteins in the network, belonging to certain complexes, 
associated with diseases that are commonly studied and have high prevalence in the human 
population.  The plasma membrane peripherome participates in cell trafficking, signal 
transduction and apoptotic processes and is consisted of proteins present in almost every 
subcellular compartment.  Certain examples presented here underline the importance of these 
proteins in the formation and functionality of the biological system they forge since their 
removal can even lead to organismal lethality (e.g. von Hippel-Lindau tumor suppressor [70-
72].  The presence of lower quality interaction data can cause problems during the analysis of 
the network. For this reason we created and analyzed an additional network consisting of 
high quality data only and observed that the basic characteristics of the network remain the 
same.  Protein-protein interaction data for membrane proteins are under-represented in public 
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databases but their study can reveal important features of membrane proteins and guide future 
experiments.  In conclusion, this study reveals certain new properties and features of the 
peripheral membrane proteins and the network created from them and their interactors; hence 
their study uncovers their pivotal role in the cell’s functionality and vitality.  The study of the 
human plasma membrane peripherome reveals potential candidates (e.g. hubs and 
bottlenecks) that can be used for further experimental studies.  Moreover, the study of various 
human cell interactomes – such as the one studied here – can be of great importance for the 
mapping and the identification of the complete human cell interactome and as Dennis Bray 
stated “we have a new continent to explore and will need maps at every scale to find our 
way” [87]. 
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Figure 1.  Visualization of graph theory parameters in the network of the human plasma 
membrane peripheral proteins with 2374 nodes and 16961 edges.  The colour gradient is 
visualized based on the clustering coefficient of each node.  In darker colours are the nodes 
with the higher clustering coefficients grading to lighter colours for nodes with lower 
clustering coefficients.  A size gradient is used to map the node degree on the network’s 
proteins.  Larger nodes are indicative of nodes with higher degrees and smaller nodes of 
nodes with lower degrees.   
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Figure 2.  Charts for four complex topological parameters of the network of the peripheral 
proteins of human plasma membrane.  A. Node degree distribution which decays as a power 
law and accentuates the scale-free properties of the network. B. Average clustering 
coefficient distribution.  C. Topological coefficient distribution.  Both the average clustering 
coefficient and topological coefficient distributions indicate that the network has a modular 
organization.  D. Betweenness centrality distribution.  This distribution shows that proteins 
with high betweenness centralities, which act as hubs are few, compared to the rest of the 
proteins in the network.   All the distributions shown above are in log-log plots. 
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Figure 3. The effect of the gradual removal of selected (attacks) and random (failure) nodes 
to the characteristic path length (CPL) of the network.  The removal (attack) of peripheral 
proteins of the human plasma membrane and proteins located in lipid rafts based on their 
node degree causes a more rapid increase of the characteristic path length of the network 
compared to the removal of random nodes (failure). 
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Figure 4. Proteins are grouped based on their subcellular location in the network of the 
human plasma membrane peripheral proteins.  1: secreted proteins, 2: membrane proteins, 3: 
peripheral proteins, 4:
 
 cytoplasmic proteins, 5: nuclear proteins, 6: endomembrane system 
proteins, 7: mitochondrial proteins,  8: lipid-anchored proteins.  The membrane proteins of 
organelles and the endomembrane system are forming circles around the other proteins of the 
organelles. Proteins with unknown subcellular location are hidden in this view of the 
network.   
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Figure 5.  A.  All the 160 complexes produced from the MCL clustering process are shown.  
In white are complexes that no biological significance could be detected and in the remaining 
colours are complexes that are associated with a certain biological function or disease.  B.  In 
this figure the complexes that are circled in A are shown.  These complexes are some 
characteristic examples of complexes with a certain biological function or disease.  The gene 
name that maps to each protein is shown for all the nodes in each cluster.  Every complex has 
a label consistent with its association. 
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Supporting Information (1) 
 
  
 Figure S1.  The sub-network of the sigma 1 subunit of the adaptor related protein 
AP2S1 (red triangle), a bottleneck, connected with 3 other proteins (magenta, red and 
blue diamonds) which are further connected with 510 other proteins in total.  
  
 Figure S2.  A four layered network created with Arena3D is shown.  The first layer 
(Diseases) consists of 31 diseases which are connected with 125 approved drugs 
grouped in 28 different drug categories as collected from DrugBank, that create the 
second layer of the network (Drugs).  These drugs interact with 31 peripheral 
membrane proteins, which constitute the third layer of the network and are grouped 
based on their subcellular location. In the fourth layer (Interactors) the proteins that 
interact with the peripheral proteins are depicted, creating the layer of interactors.  
These protein interactors are grouped based on their association with the membrane 
plane in six categories (multi-pass transmembrane proteins, single-pass 
transmembrane proteins, peripheral membrane proteins, secreted proteins, intracellular 
proteins and other).  An example of the connections between Alzheimer’s disease and 
the drugs associated with it (DrugBank IDs: DB00163, DB00144, DB02381), the 
peripheral proteins of the human plasma membrane interacting with these drugs 
(Q16760, P17252, Q8N3E9, O95810, P15692) and the interactors of these proteins. 
 Figure S3.  Two complexes with novel components produced from the MCL 
clustering process are shown.  The first complex is the endosomal sorting required for 
transport complex III (ESCRT-III complex).  The second complex is the mammalian 
target of rapamycin complex 2 (mTORC2) which functions as an important regulator 
of the cytoskeleton.  Proteins that represent previously reported components of the 
complex are shown in yellow, while novel subunits are shown in pink. 
 
